Biomarkers in axial spondyloarthritis diagnosis: from clinical signs to multi-omics integration
It is concluded that biomarker-driven precision diagnosis in axSpA requires continued biomarker discovery alongside the construction of shared infrastructure—multi-modal datasets, standardized pipelines, and prospective validation cohorts—to integrate existing and emerging biomarkers into clinically deployable tools.